smooth and striated muscle cells, and endothelial cells (63) .
In nonmuscle cells, caveolin-1 is the main structural protein component of caveolae. Caveolin-1 drives caveolae formation through oligomerization (with itself and with caveolin-2) and by interacting with cholesterol (39, 53, 59) . The formation of this functional assembly unit may facilitate targeting of numerous constituents to caveolae, including proteins involved in signal transduction (reviewed in Refs. 1, 42, and 67) .
Caveolae have a very specific lipid composition; they are highly enriched in cholesterol and sphingomyelin. This has led to the hypothesis that caveolae may play a role in the regulation of cellular cholesterol homeostasis. The observation that caveolin-1 binds cholesterol specifically (47, 75) suggests that caveolin-1 may play a direct role in this process. Recently, Smart et al. (69) demonstrated that caveolin-1, coupled with other chaperone proteins, facilitates transport of cholesterol from the endoplasmic reticulum to the plasma membrane. Other studies (21) have indicated that free cholesterol (FC) selectively transferred from low-density lipoprotein (LDL) to cells appears first in clathrincoated pits and is eventually transferred to caveolae via the trans-Golgi network. Furthermore, some investigators (22) also showed that plasma membrane caveolae can mediate cellular cholesterol efflux to plasma or high-density lipoprotein (HDL) using this specific cholesterol-labeling procedure. Additionally, Bist et al. (5) have recently demonstrated that caveolin-1 expression is under the positive control of cellular cholesterol levels.
The importance of HDL in cholesterol elimination has been suggested by several epidemiological studies that show an inverse correlation between the development of coronary artery disease and HDL cholesterol levels (9, 31, 32, 46, 79) . This has led to the concept of reverse cholesterol transport, a process by which HDL removes excess peripheral cholesterol and transfers it to the liver for degradation and removal from the body (20) . HDL particles are believed to function as the primary acceptors of cellular cholesterol. After cellular cholesterol efflux to HDL, cholesterol is esterified and transferred to apolipoprotein B-containing lipoproteins via the cholesterol ester transfer protein (20) . However, the specific mechanisms involved in the removal of cellular cholesterol by apolipoprotein A-I-containing HDL particles are still poorly understood (24, 49) .
The present study was designed to determine whether caveolin-1 protein expression specifically effects total cellular cholesterol efflux mediated by HDL. Our results indicate that caveolin-1 downregulation enhances cellular cholesterol efflux to HDL. Moreover, we show that chronic HDL exposure leads to the downregulation of caveolin-1 expression, a process that may be relevant to understanding the pathogenesis of coronary heart disease. Cruz, CA). PD-98059 and U-0126 were purchased from Calbiochem and Promega, respectively. 1,1Ј-Dioctadecyl-3,3,3Ј,3Ј-tetramethylindocarbocyanine perchlorate (DiI) was obtained from Molecular Probes (Eugene, OR). The cDNA for murine caveolin-1 was as we described previously (73) .
MATERIALS AND METHODS

Materials
[1␣,2␣-3 H]cholesterol was purchased from NEN (Boston, MA). All other reagents were analytical grade.
Cell culture. Normal and transformed NIH/3T3 cells were cultured in a CO2 incubator at 37°C in DMEM high glucose, 10% donor calf serum (DCS), 4 mM glutamine, and antibiotics (100 U/ml penicillin and 100 g/ml streptomycin). NIH/ 3T3 cell lines harboring caveolin-1 antisense were as previously described (27) and were maintained in media containing 150 g/ml hygromycin B to prevent spontaneous loss of the caveolin-1 antisense vector. The human microvascular endothelial cell line (HMEC-1; obtained from the Biological Products Branch of the Centers for Disease Control, Atlanta, GA) was grown in MCDB-131 containing 10% fetal bovine serum (FBS).
Isolation of lipoproteins. HDL 3 and LDL from human plasma were purified by sequential ultracentrifugation, as previously described (65) . Oxidized LDL (oxLDL) was prepared by incubating LDL with 10 M CuSO4 at 37°C for 16 h. OxLDL was extensively dialyzed against PBS, and oxidation was monitored by submitting oxLDL to a precast 0.5% agarose gel electrophoresis (Lipogel; Beckman). Labeling with DiI was performed as described by others (71) . Purified DiI-labeled oxLDL was obtained after ultracentrifugation and extensive dialysis.
Cellular cholesterol efflux. Cells in complete medium were seeded in six-well plates at a density of 2 ϫ 10 4 cells/well. After 48 h, the medium was replaced with DMEM supplemented with 5% DCS and 5 Ci/ml [ 3 H]cholesterol dispersed in 0.1% ethanol (% final volume of media) for 48 h. Before each efflux experiment, cells were washed three times with DMEM and then incubated with DMEM containing HDL3 (50 g/ml) and 0.2% BSA. Media aliquots were taken at different times of incubation and treated as previously described (25) . At the end of the experiment, cells were solubilized in 0.5 N NaOH to determine protein and [ 3 H]cholesterol content. Results presented are expressed as the percentage of labeled cholesterol remaining in the cells as a function of time.
Determination of cellular cholesterol content. Cellular cholesterol was extracted from cells using isopropanol. Cholesterol content was determined using a colorimetric test (Sigma cholesterol determination kit).
Activation of p42/44 MAP kinase pathway. To determine the activation state of ERK1/2 (p42/44), cells were lysed in boiling SDS sample buffer and samples were then collected and boiled for another 5 min. After SDS-PAGE (12% polyacrylamide) and transfer to nitrocellulose (0.2 m), blots were probed with primary antibodies (dilution 1:1,000; New England Biolabs) and the appropriate horseradish peroxidase-conjugated secondary antibody (dilution 1:5,000; Transduction Laboratories). Bound antibodies were visualized using enhanced chemiluminescence.
Caveolin-1 promoter construct. The caveolin gene promoter was cloned into pA3 Luc (16), a luciferase reporter plasmid (44, 81) . In this study, we used a promoter construct that contains ϳ3 kb upstream of the caveolin-1 ATG, caveolin-1/ exon 1, caveolin-1/intron 1, and a portion of caveolin-1/exon 2 (described as Pr-3 kb and Int 1 in Ref. 16) .
Luciferase assays. Transient transfections (using calcium phosphate precipitation) and luciferase assays were performed essentially as we described previously (13, 14) . Briefly, 300,000 cells (HEK-293T cells) were seeded in sixwell plates 12-24 h before transfection. Each well was transfected with 1 g of each plasmid for experiments in which two plasmids were cotransfected. Twelve hours posttransfection, the cells were rinsed twice with PBS and incubated for 24 h in DMEM containing 0.2% BSA with or without 500 g/ml of HDL 3. The cells were then lysed in 200 l of extraction buffer, of which 100 l were used to measure luciferase activity, as described (50) . Cotransfection with pSV-␤-galactosidase was used as an internal control to normalize for transfection efficiency.
Regulation of SREBP-1 cellular localization. NIH/3T3 cells were incubated with or without HDL 3 for 24 h and fixed with PBS/2% paraformaldehyde. After permeabilization (PBS/ 0.1% Triton X-100 and 0.2% BSA), cells were incubated with anti-SREBP-1 polyclonal antibody (PAb). Detection of bound IgG was performed using a Rhodamine Red-X F(abЈ) 2 goat anti-rabbit IgG (Jackson Immunoresearch Laboratories, West Grove, PA). Immunofluorescence was observed with a 12-bit Photometrics cooled charge-coupled device (CCD) camera mounted on an Olympus IX70 inverted microscope.
Cellular uptake of DiI-labeled oxLDL. For cellular uptake studies, HMEC-1 were seeded in 24-well plates containing coverslips. After 24 h in MCDB-131 media containing 10% FBS, cells were washed with media alone and incubated with either MCDB-131 or MCDB-131 containing 500 g/ml HDL 3 for 24 h. Media was then replaced with 50 g/ml DiI-labeled oxLDL for 2 h at 37°C. At the end of the experiments, cells were washed with PBS. Immunofluorescence was observed with a 12-bit Photometrics cooled CCD camera mounted on an Olympus IX70 inverted microscope. Figure 1A shows loss of caveolin-1 expression in cells transformed with the activated oncogenes v-Abl and H-Ras (G12V). Caveolin-2 expression levels were much less affected by cellular transforma-tion (Fig. 1A) . Thus we examined the ability of HDL 3 to promote cellular cholesterol efflux from these three different cell lines. Results presented in Fig. 1B show the percentage of cellular cholesterol (radiolabeled) remaining in the cells upon incubation with HDL 3 . The results indicate that in v-Abl and H-Ras transformed cells, efflux is more active than in the parental cell line. These differences are already significant after 0.5-1 h of incubation.
RESULTS
Cholesterol efflux from normal and transformed NIH/3T3 cells.
Effect of caveolin-1 downregulation on cellular cholesterol efflux mediated by HDL 3 . Because the NIH/3T3 cell lines used in Fig. 1 are transformed by activated oncogenes, factors other than caveolin-1 downregulation could mediate the observed increase in cellular cholesterol efflux to HDL 3 . To evaluate the role of caveolin-1 expression directly, we next employed an antisense-based approach. We previously developed an NIH/3T3 cell line in which caveolin-1 protein expression levels are downregulated by stable transfection with a caveolin-1 antisense vector (27) . We therefore decided to examine the ability of HDL 3 to promote cellular cholesterol efflux from this cell line [termed Cav-1-AS (27) ] and compared it with two other cells, parental NIH/3T3 cells and a revertant of Cav-1-AS (named Rev-Cav-1-AS), which were grown in the absence of selection marker (hygromycin) and have lost the antisense vector (27) , restoring normal caveolin-1 expression. This revertant was shown to behave the same as the parental cell line. Figure 2A shows that caveolin-1 expression was clearly reduced in the antisense cell line compared with other positive controls (parental NIH/3T3 and Rev-Cav-1-AS), whereas caveolin-2 was not affected ( Fig. 2A) . Figure 2B shows that HDL 3 promoted cellular cholesterol efflux from the parental and revertant cell lines with very similar efficiencies. However, cholesterol efflux from the Cav-1-AS cell line was significantly enhanced compared with the other cell lines.
Total cellular cholesterol content is independent of caveolin-1 expression. Previous studies (4) have indicated that cellular cholesterol content influences the ability of HDL to promote cellular cholesterol efflux. Because caveolin-1 has been implicated in the regulation of cellular cholesterol homeostasis, downregulation of this protein could dramatically affect cellular cholesterol content. We therefore determined the cholesterol content of the cell lines used in this study. Table 1 shows that despite greatly reduced caveolin-1 expression levels, the cellular cholesterol content of H-Ras-and v-Abl-transformed cells, as well as the Cav-1-AS cell line, was similar to that of the parental and Rev-Cav-1-AS cell lines.
Chronic HDL 3 exposure downregulates the expression of caveolin-1 in NIH/3T3 cells. To determine whether caveolin-1 expression levels were correlated with cellular cholesterol content, NIH/3T3 cells were depleted of cholesterol by incubation with varying HDL 3 concentrations, and both caveolin-1 and -2 expression levels were determined after a 24-h incubation. Figure 3A shows an immunoblot of the cellular extracts solubilized after incubation with HDL 3 . It demonstrates that while caveolin-2 expression levels remained unchanged with or without HDL in the media, caveolin-1 expression was downregulated by HDL.
Relationship between HDL-mediated p42/44 MAP kinase activation and caveolin-1 expression. To determine whether HDL 3 could act via the p42/44 MAP kinase pathway, NIH/3T3 cells were incubated with HDL 3 for 24 h, and activation of p42/44 MAP kinase was assessed by determining the level of activated (phosphorylated) p42/44 proteins (ERK1 and ERK2), using phophospecific antibody probes (Fig. 3B) . Results presented in Fig. 3B show that at high HDL 3 concen- Cell lysates were prepared from the different cell lines and separated by 12% SDS-PAGE. After transfer to nitrocellulose, caveolin-1 and -2 expression was detected using monoclonal antibodies (MAbs) 2297 and 65, respectively. Note that caveolin-1 is reduced in transformed cells, whereas caveolin-2 expression levels are less affected, as previously observed (36) . B: cholesterol efflux. Cells were labeled in the presence of [ 3 H]cholesterol (see MATERIALS AND METH-ODS) and then incubated with HDL3 (50 g/ml). Aliquots of media were removed at the indicated times and counted. Efflux is expressed as the percentage of [ tration (Ͼ100 g/ml), the p42/44 MAP kinase pathway is activated. However, downregulation of caveolin-1 at the lowest concentration of HDL 3 does not appear to correlate with ERK1/2 activation (compare Fig. 3, A  and B) .
Activation of ERK1 and ERK2 is mediated by MEK1 and MEK2 and can be blocked by the inhibitor PD-98059. In previous studies, we have shown that caveolin-1 downregulation mediated by transformation with activated Ras (G12V) could be reversed by inhibiting MEK1/2 with PD-98059 (13, 27) . To determine whether PD-98059 could reverse HDL 3 -mediated caveolin-1 downregulation, NIH/3T3 cells were incubated with HDL 3 with or without the inhibitor. Results presented in Fig. 4 indicate that despite reduced activation of p42/44 MAP kinase, incubation of the cells with PD-98059 did not abolish caveolin-1 downregulation, suggesting that another mechanism of control for this protein is operating in the presence of HDL 3 , possibly via downregulation of cellular cholesterol content.
A novel potent MEK inhibitor (17), U-0126, has recently been characterized and was shown to also inhibit the active phosphorylated form of MEK (17). In Fig. 2 . Effect of caveolin-1 downregulation on cellular cholesterol efflux mediated by HDL3. A: Western blot analysis. Cell lysates were prepared from the different cell lines and separated by 12% SDS-PAGE. After transfer to nitrocellulose, caveolin-1 and -2 expression was detected using MAbs 2297 and 65, respectively. Caveolin-1 is reduced in the antisense cell line, whereas caveolin-2 expression levels remain unaffected (27) . B: cholesterol efflux. Cells were labeled in the presence of contrast, PD-98059 only inhibits nonphosphorylated MEK and has no effect on phosphorylated active MEK. In a separate experiment, we determined the effect of this new inhibitor on caveolin-1 expression. Interestingly, we observed that caveolin-1 expression was upregulated by U-0126 in the presence of serum, but not with PD-98059 (data not shown). However, upregulation of caveolin-1 could not be achieved in the presence of HDL and U-0126 (Fig. 5) .
Effects of chronic HDL exposure on caveolin-1 gene transcription. The caveolin-1 promoter has been isolated and characterized by our laboratory (16) and others (5) . To determine whether incubation of cells with HDL 3 affects caveolin-1 promoter activity, we next incubated cells transfected with a luciferase expression vector under the control of the caveolin-1 promoter (Fig. 6A) in the presence or absence of HDL 3 . Our results demonstrate that under the conditions of the assay, HDL inhibits caveolin-1 promoter transcriptional activity by ϳ50% (Fig. 6B) . Thus chronic HDL exposure can negatively regulate caveolin-1 gene transcription.
Incubation of NIH/3T3 cells with HDL 3 induces translocation of the active form of SREBP-1 to the nucleus.
To determine whether SREBP-1 might be involved in the downregulation of caveolin-1, experiments were performed to analyze the effect of HDL 3 on SREBP-1 translocation to the nucleus. For this purpose, we used a rabbit PAb directed against the SREBP-1 NH 2 -terminal domain, which is cleaved from the COOH terminus and represents the active transcription factor transferred to the nucleus (8) . Figure 7 shows that incubation of NIH/3T3 cells with HDL 3 induces the translocation of SREBP-1 to the nucleus. Importantly, this translocation event is not observed after treatment with media alone (see Fig. 7A ).
HDL-induced downregulation of caveolin-1 prevents the uptake of oxLDL in endothelial cells. Numerous morphological studies have suggested that caveolae may be involved in the transcytosis of modified lipoproteins across endothelial cells. Thus we next examined the effect of HDL-induced downregulation of caveolin-1 on the ability of endothelial cells to take up oxLDL. As a prerequisite for these studies, we found that caveolin-1 was downregulated after HDL 3 treatment of endothelial cells (Fig. 8A) .
We used DiI-labeled oxLDL to determine the extent of oxLDL uptake in HMEC-1 cells. As shown in Fig. 8 , B and C, endothelial cells preincubated with media alone take up oxLDL very efficiently. In contrast, endothelial cells preincubated with HDL 3 could only bind Fig. 5 . Comparison of the effect of PD-98059 and U-0126 on caveolin-1 downregulation mediated by HDL3. NIH/3T3 cells were seeded in 6-well plates, and after 1 day in complete media, cells were washed 3 times with DMEM alone. Media containing BSA (0.2%) and HDL3 (500 g/ml) plus vehicle alone (HDL/DMSO) or the MEK inhibitor [HDL/PD-98059 (50 M) or HDL/U-0126 (10 M)] was then added to the wells. After 24 h, cells were lysed, and lysates were analyzed by 12% SDS-PAGE. After transfer to nitrocellulose, activated p42/44 MAP kinase (ERK1/2) was detected using a phosphospecific antibody. In parallel, caveolin-1 and -2 expression was also monitored using MAbs 2297 and 65, respectively. Results shown are representative of several independent experiments. Fig. 4 . Effect of the PD-98059 inhibitor on caveolin-1 downregulation mediated by HDL3. NIH/3T3 cells were seeded in 6-well plates, and after 1 day in complete media, cells were washed 3 times with DMEM alone. Media containing BSA (0.2%) alone (CTL), HDL3 (500 g/ml) plus vehicle alone (HDL/DMSO), or HDL3 (500 g/ml) plus PD-98059 (50 M) (HDL/PD) was then added to the wells. After 24 h, cells were lysed, and lysates were analyzed by 12% SDS-PAGE. After transfer to nitrocellulose, activation of phosphorylated p42/44 was detected using a phosphospecific antibody. In parallel, caveolin-1 expression was also monitored using MAb 2297. Results shown are representative of several independent experiments. oxLDL at the cell surface but failed to internalize oxLDL.
DISCUSSION
Several studies have now implicated caveolin-1 in the regulation of cellular cholesterol homeostasis (18, 19, 21, 22, 33, 68, 69) . These studies have indicated that FC selectively transferred from LDL to cells appears first in clathrin-coated pits and is eventually transferred to caveolae via the trans-Golgi network (21) . Moreover, caveolin-1 is now known to bind cholesterol with a high affinity (47, 75) , and it appears that its expression is under the positive control of cellular cholesterol levels (5) .
In support of a role for caveolin-1 in cholesterol metabolism, it was shown that plasma membrane caveolae can mediate cellular cholesterol efflux to HDL or plasma (22) . To directly determine whether caveolin-1 is involved in this process, we have used three different NIH/3T3 cell lines that lack normal levels of caveolin-1 expression (2 cell lines transformed with activated oncogenes, such as v-Abl and H-Ras, and another cell line harboring caveolin-1 antisense). Cellular cholesterol efflux mediated by HDL 3 was examined in these cells and compared with parental NIH/ 3T3 cells. Our current results clearly demonstrate that caveolin-1 downregulation enhances cellular cholesterol efflux. Moreover, we also show that HDL 3 can negatively regulate caveolin-1 expression, possibly by decreasing cellular cholesterol levels.
Mechanism of cellular cholesterol efflux mediated by HDL. Caveolae are plasma membrane domains that are enriched in cholesterol and sphingomyelin relative to the rest of the plasma membrane. Studies have indicated that transfer of cellular cholesterol to an acceptor may be a function of the existence of different microdomains with varying cholesterol content (2, 55). Of particular importance for this study is the fact that sphingomyelin preferentially interacts with cholesterol and has been shown to decrease sterol transfer between membranes (2) . In agreement with this idea, we show in the present study that cholesterol efflux in cells that contain a decreased number of caveolae (36) and presumably reduced sphingomyelin/cholesterolenriched plasma domains can transfer cholesterol to an acceptor faster than control cells. In this case, cholesterol could be transferred from intracellular stores to the plasma membrane via a pathway that may not involve caveolin-1. Numerous studies have demonstrated the existence of different cellular cholesterol pools that can efflux cholesterol with varying halftimes (34, 43, 54, 55, 82) . Our current results may reflect a reorganization of the different pools of cholesterol into faster effluxing pools when caveolin-1 is downregulated.
Earlier studies (18) found that downregulation of caveolin-1 leads to reduced cellular cholesterol efflux to media containing serum. This apparent contradiction with our study may suggest that cellular cholesterol efflux mediated by caveolae and caveolin-1 requires other plasma factors, such as 1) pre-␤ 1 -HDL, which are smaller than HDL 3 and may therefore be able to enter caveolae more easily. This view is supported by the work of Saito et al. (57), who suggested that apo-A-I (the major pre-␤ 1 -HDL protein) has a high affinity for cholesterol-enriched plasma domains. However, studies by Gillotte et al. (28) did not show that pre-␤-HDL could specifically access caveolae domains to promote cellular cholesterol removal. 2) Phospholipid transfer protein (PLTP) could help promote efflux from caveolae (37) . This plasma enzyme has recently been shown to enhance cellular cholesterol efflux to HDL (80) . Interestingly, the effect mediated by PLTP is induced by cholesterol loading and inhibited by brefeldin A. Cholesterol loading is known to increase caveolin-1 expression levels, whereas brefeldin A has been shown to block the appearance of caveolin-1 in the Golgi without preventing it from leaving the membrane (68) . The mechanism by which PLTP may act remains elusive; however, Wolfbauer et al. (80) have suggested that it may promote cell surface binding of HDL 3 , possibly at the caveolae level.
Several studies have attempted to determine the signaling pathways that are activated by HDL. Two major pathways have been implicated, and they were both shown to enhance cellular cholesterol efflux to HDL or apo-A-I. Mendez et al. (45) showed that activation of the protein kinase C pathway could enhance cellular cholesterol efflux and that this effect was specific to HDL. Other studies have implicated a cAMPmediated pathway (35, 58) . We have shown that caveolin-1 can inhibit both these pathways (48, 51). These were seeded in 6-well plates, and after 1 day in complete media, cells were washed 3 times with media alone. Cells were then incubated with either MCDB-131 media alone or MCDB-131 media containing 500 g/ml HDL3. After 24 h, cells were lysed, and the lysates were analyzed by 12% SDS-PAGE. Caveolin-1 expression was detected using MAb 2297. Note that chronic HDL exposure downregulates caveolin-1 expression in endothelial cells. B and C: HMEC-1 were seeded in 24-well plates containing coverslips. After 24 h in MCDB-131 media containing 10% fetal bovine serum, cells were washed with media alone and incubated with either MCDB-131 or MCDB-131 containing 500 g/ml HDL3 for 24 h. Media was then replaced with 50 g/ml 1,1Ј-dioctadecyl-3,3,3Ј,3Ј-tetramethylindocarbocyanine perchlorate-labeled ox-LDL for 2 h at 37°C. Fluorescence was observed with a 12-bit Photometrics cooled CCD camera mounted on an Olympus IX70 inverted microscope. B: HMEC-1 cells pretreated with media alone. C: HMEC-1 cells pretreated with media containing 500 g/ml HDL3. Arrows indicate the position of the plasma membrane. Note that oxLDL is taken up in cells pretreated with media alone, whereas oxLDL remains at the cell surface in cells pretreated with media containing HDL3.
observations are consistent with our current results and may indicate that caveolin-1 controls cellular cholesterol efflux mediated by HDL 3 by regulating one or both pathways.
Recent studies have characterized ATP-binding cassette 1 (ABC1) as an important mediator of cellular cholesterol efflux (5a, 7, 38, 52, 56) . ABC1 mRNA transcription can vary greatly among different cell lines, and these variations have been positively correlated to cell cholesterol efflux mediated by apo-A-I or HDL (6) . In addition, ABC1 mRNA transcription can be enhanced in the presence of cAMP (38, 72) , a process that suggests a protein kinase A-dependent transcriptional activation. Since caveolin-1 was shown to inhibit protein kinase A activation, downregulation of caveolin-1 may dramatically affect ABC1 expression in transformed NIH/3T3 cells, and, consistent with our finding, may enhance cellular cholesterol efflux to HDL.
Regulation of caveolin-1 expression: importance of HDL, cellular FC, and the MAP kinase pathway. In this study, we show for the first time that HDL can downregulate caveolin-1 expression levels without affecting caveolin-2. Consistent with the studies of Deeg et al. (11), we observed that HDL could activate the MAP kinase pathway through the activation of ERK1/2. Previous studies from our laboratory have demonstrated that activation of this pathway generally leads to the downregulation of caveolin-1 expression (15, 27) . This result is consistent with that found by Furuchi and Anderson (26) , who showed that shortterm treatment with cyclodextrin could lead to activation of the MAP kinase pathway by specifically depleting caveolae cholesterol.
We have previously found that inhibition of the MAP kinase pathway using PD-98059 could prevent the downregulation of caveolin-1 in H-Ras (G12V)-transformed NIH/3T3 cells (15) . However, when this inhibitor was added to the medium in the presence of HDL, caveolin-1 expression levels remained similar to those found in cells treated with HDL alone and lower than the control cells incubated without HDL (Fig. 4) . This result suggests that caveolin-1 expression is also regulated by factors other than the p42/44 MAP kinase cascade. In support of this possibility, Bist et al. (5) have recently demonstrated that the promoter of the caveolin-1 gene contains two sterol regulatory-like elements. In the present study, we show that incubation of NIH/3T3 cells with HDL can induce the translocation of SREBP-1 into the nucleus. This result suggests that SREBP-1 can prevent CAV-1 transcription as previously shown (5) . In addition, these investigators also showed that SREBP-1 can bind the CAV-1 promoter in gel shift analysis and DNase I footprinting experiments. More recent studies by Fra et al. Physiological significance: HDL-induced downregulation of caveolin-1 and the uptake of oxLDL. Endothelial cells express high levels of caveolin-1 and are, therefore, highly enriched in caveolae (42) . Caveolae are involved in a number of cellular events, including transcytosis (12, 66) . One of the earliest events that leads to the development of an atheroma may involve the transfer of oxLDL from the luminal side of the artery to the subendothelial space (66) . Interestingly, SR-BI and CD36, both of which bind oxLDL, have been localized to caveolae and are expressed in endothelial cells (2, 42, 77) .
In the present work, we have demonstrated that HDL can downregulate caveolin-1 expression and may, therefore, prevent the uptake of oxLDL. To test this hypothesis, we examined the effect of HDL 3 on the ability of endothelial cells to take up oxLDL. For this purpose, we employed the ligand DiI-labeled oxLDL. We show that pretreatment of endothelial cells with HDL 3 downregulates caveolin-1 expression and prevents uptake of oxidized LDL without inhibiting its binding to the plasma membrane. These data indicate that oxLDL receptors are still functional at the plasma membrane, but that ligand uptake is prevented when caveolin-1 is downregulated. These results provide further evidence that caveolae and caveolin-1 are part of a pathway that allows endothelial cells to take up and process oxLDL. Together, these findings may suggest a new mechanism to explain the antiatherogenic effects of HDL: HDL could reduce the transfer of atherogenic lipoproteins from the blood to the subendothelial space by reducing the number of caveolae available for transcytosis at the surface of endothelial cells. A direct test of this hypothesis in vivo will require the generation of a caveolin-1 null (Cav-1 Ϫ/Ϫ) mouse animal model.
